Hadley Wilson, MD
PeerAngiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Akshay S. Desai, MD
PeerMarc Bonaca, MD
PeerPromising results for APOC3 ASO in familial chylomicronemia syndrome
Erik Stroes, MD, PhD
PeerIncreasing the use of SGLT2i and GLP-1RA with a remote program in T2D and high CV or kidney risk
Alexander J. Blood, MD
PeerSteven Nissen, MD
PeerDeep Learner: Building AI to Improve Cardiovascular Care
Pierre Elias, MD
PeerAgainst the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
Christopher Petit, MD
PeerConfronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Michael Bloch, MD
PeerConversations With Cardiologists: Clinical Perspectives on the Treatment of HFmrEF and HFpEF
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Overcoming Real World Challenges of LDL-C Management: Looking Beyond Statin Therapy